loading
Schlusskurs vom Vortag:
$1.39
Offen:
$1.39
24-Stunden-Volumen:
163.74K
Relative Volume:
0.39
Marktkapitalisierung:
$79.96M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-64.86M
KGV:
-1.1786
EPS:
-1.12
Netto-Cashflow:
$-55.66M
1W Leistung:
-8.33%
1M Leistung:
+4.76%
6M Leistung:
+3.13%
1J Leistung:
-46.12%
1-Tages-Spanne:
Value
$1.30
$1.39
1-Wochen-Bereich:
Value
$1.30
$1.47
52-Wochen-Spanne:
Value
$0.8551
$3.36

Acumen Pharmaceuticals Inc Stock (ABOS) Company Profile

Name
Firmenname
Acumen Pharmaceuticals Inc
Name
Telefon
617-344-4190
Name
Adresse
1210-1220 WASHINGTON STREET, NEWTON
Name
Mitarbeiter
52
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-31
Name
Neueste SEC-Einreichungen
Name
ABOS's Discussions on Twitter

Vergleichen Sie ABOS mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ABOS
Acumen Pharmaceuticals Inc
1.32 81.77M 0 -64.86M -55.66M -1.12
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
394.53 99.62B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
465.89 61.52B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.00 58.91B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
756.38 46.69B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
324.34 34.54B 3.81B -644.79M -669.77M -6.24

Acumen Pharmaceuticals Inc Stock (ABOS) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-06-17 Eingeleitet Citigroup Buy
2024-07-26 Eingeleitet Citigroup Buy
2023-12-12 Eingeleitet Deutsche Bank Buy
2023-07-20 Fortgesetzt BofA Securities Buy
2023-05-18 Eingeleitet Cantor Fitzgerald Overweight
2022-07-15 Eingeleitet BTIG Research Buy
2022-06-30 Eingeleitet H.C. Wainwright Buy
2022-01-21 Hochstufung BofA Securities Neutral → Buy
2021-07-26 Eingeleitet BofA Securities Neutral
2021-07-26 Eingeleitet Credit Suisse Outperform
2021-07-26 Eingeleitet Stifel Buy
2021-07-26 Eingeleitet UBS Buy
Alle ansehen

Acumen Pharmaceuticals Inc Aktie (ABOS) Neueste Nachrichten

pulisher
Sep 12, 2025

Acumen Pharmaceuticals’ Earnings Call Highlights Strategic Growth - MSN

Sep 12, 2025
pulisher
Sep 12, 2025

Is Acumen Pharmaceuticals Inc. still worth holding after the dipEarnings Growth Summary & Weekly Market Pulse Updates - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Combining machine learning predictions for Acumen Pharmaceuticals Inc.Weekly Earnings Recap & Safe Entry Point Identification - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Predicting Acumen Pharmaceuticals Inc. trend using moving averagesInsider Selling & AI Powered Market Trend Analysis - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

What recovery options are there for Acumen Pharmaceuticals Inc.July 2025 Momentum & Accurate Entry and Exit Point Alerts - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Will Acumen Pharmaceuticals Inc. bounce back from current supportBull Run & Weekly High Momentum Picks - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

What earnings revisions data tells us about Acumen Pharmaceuticals Inc.Earnings Summary Report & Breakout Confirmation Trade Signals - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Live market analysis of Acumen Pharmaceuticals Inc.2025 Performance Recap & Technical Pattern Based Signals - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Risk vs reward if holding onto Acumen Pharmaceuticals Inc.2025 Fundamental Recap & Daily Volume Surge Trade Alerts - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Using flow based indicators on Acumen Pharmaceuticals Inc.Trade Signal Summary & Growth Oriented Trading Recommendations - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Technical signs of recovery in Acumen Pharmaceuticals Inc.July 2025 Closing Moves & Stepwise Entry and Exit Trade Signals - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Building trade automation scripts for Acumen Pharmaceuticals Inc.Portfolio Gains Report & High Win Rate Trade Alerts - Newser

Sep 12, 2025
pulisher
Sep 11, 2025

Can you recover from losses in Acumen Pharmaceuticals Inc.2025 Sector Review & Consistent Profit Trading Strategies - Newser

Sep 11, 2025
pulisher
Sep 11, 2025

Leading vs lagging indicators on Acumen Pharmaceuticals Inc. performance2025 Biggest Moves & Short-Term Trading Opportunity Alerts - Newser

Sep 11, 2025
pulisher
Sep 11, 2025

Will Acumen Pharmaceuticals Inc. price bounce be sustainableJuly 2025 EndofMonth & Daily Profit Focused Screening - Newser

Sep 11, 2025
pulisher
Sep 11, 2025

Should you wait for a breakout in Acumen Pharmaceuticals Inc.Earnings Risk Summary & Reliable Price Breakout Signals - Newser

Sep 11, 2025
pulisher
Sep 11, 2025

Can machine learning forecast Acumen Pharmaceuticals Inc. recovery2025 Trading Volume Trends & Real-Time Buy Signal Notifications - Newser

Sep 11, 2025
pulisher
Sep 11, 2025

What MACD signals say about Acumen Pharmaceuticals Inc.Trade Analysis Report & AI Powered Buy/Sell Recommendations - Newser

Sep 11, 2025
pulisher
Sep 10, 2025

Multi factor analysis applied to Acumen Pharmaceuticals Inc2025 Top Gainers & Safe Entry Momentum Tips - Newser

Sep 10, 2025
pulisher
Sep 10, 2025

Can a trend reversal in Acumen Pharmaceuticals Inc. lead to recoveryJuly 2025 Spike Watch & Daily Chart Pattern Signal Reports - Newser

Sep 10, 2025
pulisher
Sep 10, 2025

What institutional flow reveals about Acumen Pharmaceuticals Inc.New Guidance & Safe Entry Momentum Tips - Newser

Sep 10, 2025
pulisher
Sep 09, 2025

Is Acumen Pharmaceuticals Inc. stock ready for a breakoutWeekly Trade Recap & Daily Profit Maximizing Tips - Newser

Sep 09, 2025
pulisher
Sep 09, 2025

Technical analysis overview for Acumen Pharmaceuticals Inc. stockJuly 2025 Sector Moves & Growth Focused Entry Reports - Newser

Sep 09, 2025
pulisher
Sep 09, 2025

Can Acumen Pharmaceuticals Inc. recover in the next quarterJuly 2025 Selloffs & Free Community Consensus Stock Picks - Newser

Sep 09, 2025
pulisher
Sep 09, 2025

Tick level data insight on Acumen Pharmaceuticals Inc. volatilityMarket Movers & Daily Volume Surge Trade Alerts - Newser

Sep 09, 2025
pulisher
Sep 09, 2025

Published on: 2025-09-09 05:33:01 - Newser

Sep 09, 2025
pulisher
Sep 09, 2025

Is Acumen Pharmaceuticals Inc. stock entering bullish territoryRecession Risk & Fast Entry Momentum Trade Alerts - Newser

Sep 09, 2025

Finanzdaten der Acumen Pharmaceuticals Inc-Aktie (ABOS)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$36.36
price down icon 0.93%
$83.10
price down icon 3.56%
$27.82
price down icon 2.76%
$96.74
price down icon 7.26%
$145.93
price up icon 0.10%
biotechnology ONC
$324.34
price down icon 3.38%
Kapitalisierung:     |  Volumen (24h):